Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements.
JAMA Netw Open
; 5(5): e225996, 2022 05 02.
Article
in English
| MEDLINE | ID: covidwho-1843822
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Buprenorphine
/
COVID-19
/
Opioid-Related Disorders
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
JAMA Netw Open
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS